Home Mycoplasmas including CBPP/CCPP [Vectored vaccines] Vectored vaccines
Mycoplasmas including CBPP/CCPP roadmap:
Vaccines

Research roadmap for contagious bovine pleuropneumonia (CBPP) vaccine development

Download CBPP vaccine development roadmap final

7

Vectored vaccines

Dependencies

Next steps

Vectored vaccines

Research Question

  1. Vectored antigen delivery systems may provoke stronger immune responses and be easier to manufacture and deliver than protein-based vaccines.

Research Gaps and Challenges

  1. Lack of in vitro assays to guide immunogenicity and efficacy testing.
  2. Regulatory restrictions for approval of vaccines derived using GMO technology.
  3. There are many viral vectored systems that could be used.

Solution Routes

  1. Assess formulations, route and dose of immunization in small-scale immunogenicity studies.
  2. Assess ability to meet minimal and desired TPPs.
  3. Assess ability to scale-up and manufacture.

Dependencies

  1. Identification of Mmm antigens that are targets of protective adaptive and innate immune responses to infection.
  2. Standardized cattle breed specific laboratory challenge models that reproduce CBPP caused by natural infection or are acceptable surrogates.

State Of the Art

  1. Experimental vaccine antigens have been identified.